Filter

I’m Hanne Verswyvel, a second year PhD student, working on a joint project between the Center for Oncological Research and the Plasma Lab for Applications in Sustainability and Medicine – ANTwerp. Starting a PhD can feel like a great leap into the unknown. Thus, I’ve put together some useful tips and strategies that can help you to get started in an organised way.

Ik ben Marion Decrop, eerstejaars masterstudente biomedische wetenschappen, met een grote passie voor jiujitsu. Een tijdje geleden mocht ik met veel trots de Francis van Loon award ontvangen als topsportstudent van het jaar. Topsport combineren met studies is niet altijd even gemakkelijk, maar het is veel leuker dan het misschien lijkt!

Despite decades of research and recent advances based on genetics and brain imaging, the exact mechanisms underlying Attention Deficit Hyperactivity Disorder (ADHD) and a viable and effective treatment are still undiscovered. Dr. Annelies Verlaet, a researcher in the NatuRA group is investigating the use of plant extracts for the treatment of ADHD.

Leishmaniasis is a neglected tropical parasitic disease caused by Leishmania species that are transmitted by the bites of female sand flies. The failure rate of leishmaniasis treatment is rising in recent years due to the emergence of resistance to the major antileishmanial drugs. Evaluating the impact of drug resistance on parasite fitness is pivotal for monitoring its development and spread.

Ook dit jaar konden de studenten van de UAntwerpen stemmen op hun favoriete studentenvertegenwoordigers, of zoals ze beter gekend zijn: de Stuvers. Maar liefst vier studenten van de Faculteit FBD hebben een centraal mandaat kunnen bemachtigen en zullen volgend academiejaar de belangen van onze faculteit en onze studenten verdedigen. Leer ze hier kennen!

Dr. Paul Fransen and colleagues from the Physiopharmacology Lab investigated the role of Nitric Oxide (NO) in controlling arterial stiffness. Given the clinical relevance of arterial stiffness as a predictor of cardiovascular risk, NO-signaling pathways could become an attractive pharmacologic target when the underlying mechanisms of arterial stiffening are fully unraveled.